Literature DB >> 33604439

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome.

Ilana D Breen1, Caitlin M Brumfiel2, Meera H Patel2, Allison C Rosenthal3, William G Rule4, David J DiCaudo2,5, Fiona E Craig5, Mark R Pittelkow2, Aaron R Mangold2.   

Abstract

Entities:  

Keywords:  CCR4, C-C chemokine receptor 4; Cutaneous T-cell lymphoma; ECP, extracorporeal photopheresis; MF, mycosis fungoides; SS, Sézary syndrome; Sézary; extracorporeal photopheresis; interface dermatitis; methotrexate; mogamulizumab

Year:  2021        PMID： 33604439      PMCID： PMC7873348          DOI： 10.1016/j.jdcr.2020.12.035

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN： 2352-5126


× No keyword cloud information.
  8 in total

1.  Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.

Authors:  E C Vonderheid; Q Zhang; S R Lessin; M Polansky; J T Abrams; R D Bigler; M A Wasik
Journal:  J Am Acad Dermatol       Date:  1998-02       Impact factor: 11.527

2.  Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response.

Authors:  Lu Chen; Kenneth R Carson; Karl W Staser; Neha Mehta-Shah; András Schaffer; Ilana S Rosman; Amy Musiek
Journal:  JAMA Dermatol       Date:  2019-08-01       Impact factor: 10.282

3.  Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

Authors:  Madan Jagasia; Hildegard Greinix; Marie Robin; Emma Das-Gupta; Ryan Jacobs; Bipin N Savani; Brian G Engelhardt; Adetola Kassim; Nina Worel; Robert Knobler; Nigel Russell; Gerard Socie
Journal:  Biol Blood Marrow Transplant       Date:  2013-04-25       Impact factor: 5.742

Review 4.  Extracorporeal photopheresis as a therapy for autoimmune diseases.

Authors:  Zoya Kuzmina; David Stroncek; Steven Z Pavletic
Journal:  J Clin Apher       Date:  2014-12-26       Impact factor: 2.821

5.  Histopathologic Characterization of Mogamulizumab-associated Rash.

Authors:  Jennifer Y Wang; Kelsey E Hirotsu; Tatiana M Neal; Shyam S Raghavan; Bernice Y Kwong; Michael S Khodadoust; Ryanne A Brown; Roberto A Novoa; Youn H Kim; Kerri E Rieger
Journal:  Am J Surg Pathol       Date:  2020-12       Impact factor: 6.394

6.  Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma.

Authors:  Takashi Ishida; Asahi Ito; Fumihiko Sato; Shigeru Kusumoto; Shinsuke Iida; Hiroshi Inagaki; Akimichi Morita; Shiro Akinaga; Ryuzo Ueda
Journal:  Cancer Sci       Date:  2013-03-10       Impact factor: 6.716

7.  Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Authors:  Youn H Kim; Martine Bagot; Lauren Pinter-Brown; Alain H Rook; Pierluigi Porcu; Steven M Horwitz; Sean Whittaker; Yoshiki Tokura; Maarten Vermeer; Pier Luigi Zinzani; Lubomir Sokol; Stephen Morris; Ellen J Kim; Pablo L Ortiz-Romero; Herbert Eradat; Julia Scarisbrick; Athanasios Tsianakas; Craig Elmets; Stephane Dalle; David C Fisher; Ahmad Halwani; Brian Poligone; John Greer; Maria Teresa Fierro; Amit Khot; Alison J Moskowitz; Amy Musiek; Andrei Shustov; Barbara Pro; Larisa J Geskin; Karen Dwyer; Junji Moriya; Mollie Leoni; Jeffrey S Humphrey; Stacie Hudgens; Dmitri O Grebennik; Kensei Tobinai; Madeleine Duvic
Journal:  Lancet Oncol       Date:  2018-08-09       Impact factor: 41.316

Review 8.  Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Amr Nassar; Ghada Elgohary; Tusneem Elhassan; Zubeir Nurgat; Said Y Mohamed; Mahmoud Aljurf
Journal:  J Transplant       Date:  2014-10-27
  8 in total
  1 in total

1.  Effective treatment of mogamulizumab-induced head and neck dermatitis with fluconazole in a patient with peripheral T-cell lymphoma.

Authors:  Ishan Asokan; Sanminder Singh; John Moesch; Jonhan Ho; Oleg E Akilov
Journal:  JAAD Case Rep       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.